EverHint – EMA 10 + Price + MACD – Top 3 Signals for Sep 10, 2026
Excerpt: 3 signals. Industrials leads (1). price range $200-$724.
What This Signal Is
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
Market Context
Broad equity markets are under modest selling pressure on September 10, 2026, with all three major indices declining roughly 0.6% in unison — a pattern that suggests broad-based risk-off sentiment rather than sector-specific weakness. The synchronized pullback across the S&P 500, Nasdaq, and Dow points to macro-driven caution, which can compress momentum signals in the short term and increase the likelihood of false breakouts for trend-following strategies like EMA/MACD crossover systems.
The VIX reading of 17.84, up sharply by over 8% on the day, is the most significant factor for intraday signal interpretation. While 17.84 remains below the historically elevated threshold of 20, the single-day spike indicates that options markets are rapidly repricing risk — a condition that tends to widen bid-ask spreads, amplify intraday price swings, and reduce the reliability of short-term momentum signals. Traders relying on EMA-price and MACD crossovers should expect more noise relative to trend clarity, and position sizing discipline becomes especially important in this environment.
Despite the broad selloff, the concentration of signals in the Industrials sector is noteworthy. Industrials tend to be cyclically sensitive and often lead during sector rotation phases when investors shift away from growth-heavy technology names — consistent with the Nasdaq's relative underperformance today. This rotation dynamic could provide a more stable momentum backdrop for Industrials-focused signals compared to the broader market, though the elevated VIX warrants tighter risk management and confirmation before acting on any single crossover signal.
🟢 Buy Signals (3 of 3 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ESLT | Elbit Systems Ltd. | Industrials | $723.91 | $33.9B |
| 2 | MOH | Molina Healthcare, Inc. | Healthcare | $200.28 | $10.5B |
| 3 | SITM | SiTime Corporation | Technology | $602.27 | $15.9B |
Field Notes
Sector concentration: Industrials (1), Healthcare (1), Technology (1)
Data coverage: 0.0% insider (7d), 0.0% congressional (30d), 0.0% earnings, 33.3% news (7d)
Peer Analysis
MOH (Molina Healthcare, Inc.): Leads 5 peers: DVA ($181.33), HSIC ($87.30), GMED ($73.56), HQY ($94.55), GRFS ($7.65)
ESLT (Elbit Systems Ltd.): Leads 5 peers: CW ($559.74), BWXT ($152.49), WWD ($332.76), AER ($140.46), AVAV ($147.06)
SITM (SiTime Corporation): Leads 5 peers: OLED ($81.16), CRUS ($116.48), ONTO ($268.92), QRVO ($112.36), BLSH ($33.88)
Recent Headlines
MOH (Molina Healthcare, Inc.)
- Cantor Fitzgerald reiterates Molina Healthcare stock rating at Neutral
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.